Breaking News Instant updates and real-time market news.

TSRO

TESARO

$147.24

-1.61 (-1.08%)

12:46
01/11/17
01/11
12:46
01/11/17
12:46

TESARO call volume above normal and directionally bullish

Bullish option flow detected in TESARO with 1,264 calls trading, 1.8x expected, and implied vol increasing almost 2 points to 54.80%. Jan-17 155 calls and Jan-18 110 puts are the most active options, with total volume in those strikes near 540 contracts. The Put/Call Ratio is 0.51. Earnings are expected on February 23rd.

  • 11

    Jan

  • 30

    Jun

TSRO TESARO
$147.24

-1.61 (-1.08%)

12/27/16
FBRC
12/27/16
NO CHANGE
Target $151
FBRC
Outperform
FBR Capital ups TESARO price target to $151
FBR Capital analyst Ed White raised his price target for TESARO to $151 from $133 and keeps the Outperform rating on the shares. The oncology-focused biopharmaceutical company closed Friday up $7.27 to $139.86. TESARO recently announced that the FDA has granted Priority Review for niraparib with a June 30, 2017 action date, White tells investors in a research note. He believes niraparib could be a potential blockbuster PARP inhibitor. Meanwhile, the launch of Varubi continues to "ramp up," with sequential quarter-over-quarter unit growth of 14%, the analyst writes. White says the drug achieved a 28% share of the oral NK-1 market in the U.S. in September.
01/04/17
GABE
01/04/17
NO CHANGE
GABE
Gabelli sees Incyte as more likely target following Gilead hire
Gilead (GILD) is more likely to buy Incyte (INCY) after naming Alessandro Riva to head its Hematology and Oncology Therapeutic unit, Gabelli analyst Jing He tells investors in a research note. Dr. Riva is a Novartis (NVS) veteran while Incyte is led by a team of Novartis veterans and has collaborated with Novartis Oncology on its key drug, Jakafi, the analyst points out. He believes Incyte is "big enough to move the needle" and bring long term growth to Gilead. The analyst lists Seattle Genetics (SGEN) and TESARO (TSRO) as other potential targets for the biotech giant. He believes Incyte is the "best fit."
01/09/17
LEER
01/09/17
NO CHANGE
Target $152
LEER
Outperform
TESARO price target raised to $152 from $115 at Leerink
Leerink analyst Seamus Fernandez raised his price target for TESARO to $152 from $115 to fully incorporate his high expectations for a broad label and reflect niraparib's transformation to a commercial stage asset. The analyst notes that the "strong data" from niraparib's NOVA trial, along with the lack of an expected FDA panel, should result in a broad label in the second-line or greater ovarian cancer maintenance setting, while ongoing niraparib trials in breast cancer and front-line ovarian cancer maintenance and the company's IO platform should be additional potential drivers of upside for the stock. Fernandez sees TESARO as an "attractive takeout target," and reiterates an Outperform rating on the shares.
01/10/17
LEER
01/10/17
NO CHANGE
LEER
Outperform
ARIAD acquisition supports potential takeout premium for TESARO, says Leerink
Leerink analyst Seamus Fernandez says the acquisition of ARIAD (ARIA) by Takeda (TKPYY) for $24 per share appears to be relatively in-line with other commercial stage acquisitions, and supports a potential acquisition price for TESARO (TSRO) of greater than $170 per share based on consensus forecasts. While TESARO remains well positioned to grow independently, the analyst believes a validated PARP inhibitor like niraparib could offer a durable and strategically important product opportunity for multiple suitors. He reiterates an Outperform rating on TESARO's shares.

TODAY'S FREE FLY STORIES

JPM

JPMorgan

$83.67

0.37 (0.44%)

15:23
01/22/17
01/22
15:23
01/22/17
15:23
Hot Stocks
JPMorgan Asset Management signs letter of intent to license Precidian technology »

JPMorgan Asset Management…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Jan

  • 16

    Feb

  • 28

    Feb

  • 14

    Jul

  • 12

    Oct

SRE

Sempra Energy

$102.44

0.36 (0.35%)

, TSLA

Tesla

$244.73

0.97 (0.40%)

15:16
01/22/17
01/22
15:16
01/22/17
15:16
Hot Stocks
Sempra unit proposes to install 'tens of thousands' of vehicle charging stations »

Sempra Energy's…

SRE

Sempra Energy

$102.44

0.36 (0.35%)

TSLA

Tesla

$244.73

0.97 (0.40%)

GM

General Motors

$37.01

-0.29 (-0.78%)

F

Ford

$12.36

-0.07 (-0.56%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Jan

  • 07

    Feb

  • 28

    Feb

QCOM

Qualcomm

$62.88

-1.56 (-2.42%)

, AAPL

Apple

$120.00

0.22 (0.18%)

15:07
01/22/17
01/22
15:07
01/22/17
15:07
Hot Stocks
Qualcomm responds to Apple suit, says actively encouraged regulatory attacks »

Qualcomm (QCOM) general…

QCOM

Qualcomm

$62.88

-1.56 (-2.42%)

AAPL

Apple

$120.00

0.22 (0.18%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Jan

  • 31

    Jan

  • 07

    Feb

  • 13

    Mar

GRAM

Grana y Montero

$4.59

-0.09 (-1.92%)

15:04
01/22/17
01/22
15:04
01/22/17
15:04
Hot Stocks
Grana y Montero says Peru pipeline won't meet financial closing deadline »

Grana y Montero issued…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

BOH

Bank of Hawaii

$88.27

1.24 (1.42%)

15:00
01/22/17
01/22
15:00
01/22/17
15:00
Hot Stocks
Bank of Hawaii appoints Shigemura as CFO, Lucien as strategy chief »

Bank of Hawaii announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Jan

ASML

ASML

$122.05

0.19 (0.16%)

, AMAT

Applied Materials

$33.84

0.09 (0.27%)

14:29
01/22/17
01/22
14:29
01/22/17
14:29
Periodicals
Applied Materials, ASML offer divergent risks, rewards, Barron's says »

As tech giants continue…

ASML

ASML

$122.05

0.19 (0.16%)

AMAT

Applied Materials

$33.84

0.09 (0.27%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Jan

ZBH

Zimmer Biomet

$113.65

-0.93 (-0.81%)

, VIA

Viacom

$44.40

1.15 (2.66%)

14:19
01/22/17
01/22
14:19
01/22/17
14:19
Periodicals
Mario Gabelli: Viacom could double in three years, Barron's says »

Speaking in the 2017…

ZBH

Zimmer Biomet

$113.65

-0.93 (-0.81%)

VIA

Viacom

$44.40

1.15 (2.66%)

VIAB

Viacom

$40.23

0.43 (1.08%)

HRI

Herc Rentals

$43.12

-0.05 (-0.12%)

CNHI

CNH Industrial

$9.25

0.21 (2.32%)

FIZZ

National Beverage

$47.14

0.82 (1.77%)

LYV

Live Nation

$27.43

0.09 (0.33%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 31

    Jan

  • 09

    Feb

  • 09

    Feb

KSU

Kansas City Southern

$87.91

3.41 (4.04%)

14:15
01/22/17
01/22
14:15
01/22/17
14:15
Conference/Events
Kansas City Southern management to meet with Loop Capital »

Meeting with EVP &…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 31

    Jan

FRTA

Forterra

$19.47

0.2 (1.04%)

14:06
01/22/17
01/22
14:06
01/22/17
14:06
Conference/Events
Forterra management to meet with RBC Capital »

Meeting to be held in New…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Jan

JE

Just Energy

$5.55

0.04 (0.73%)

14:03
01/22/17
01/22
14:03
01/22/17
14:03
Conference/Events
Just Energy management to meet with RBC Capital »

Meeting to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

PRU

Prudential

$105.59

0.83 (0.79%)

14:01
01/22/17
01/22
14:01
01/22/17
14:01
Conference/Events
Prudential management to meet with RBC Capital »

Meeting to be held in San…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Jan

  • 09

    Feb

  • 05

    Mar

  • 06

    Jun

NFLX

Netflix

$138.60

0.19 (0.14%)

13:53
01/22/17
01/22
13:53
01/22/17
13:53
Periodicals
'Risky' to bet against Netflix, Barron's says »

Despite rising content…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Feb

CYNO

Cynosure

$43.85

-0.15 (-0.34%)

, AGN

Allergan

$214.34

-0.24 (-0.11%)

13:48
01/22/17
01/22
13:48
01/22/17
13:48
Periodicals
Cynosure explores strategic alternatives, Bloomberg says »

Cynosure (CYNO) is…

CYNO

Cynosure

$43.85

-0.15 (-0.34%)

AGN

Allergan

$214.34

-0.24 (-0.11%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 07

    Feb

  • 08

    Feb

CF

CF Industries

$34.20

1.95 (6.05%)

13:41
01/22/17
01/22
13:41
01/22/17
13:41
Periodicals
CF Industries investors should take profits, Barron's says »

CF Industries…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

DIS

Disney

$107.66

0.38 (0.35%)

13:36
01/22/17
01/22
13:36
01/22/17
13:36
Periodicals
Disney remains challenged, Barron's says »

Nagging challenges remain…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 07

    Feb

YHOO

Yahoo

$42.05

-0.04 (-0.10%)

, VZ

Verizon

$52.72

0.36 (0.69%)

13:28
01/22/17
01/22
13:28
01/22/17
13:28
Periodicals
Yahoo looks appealing, Barron's says »

Yahoo (YHOO) "looks…

YHOO

Yahoo

$42.05

-0.04 (-0.10%)

VZ

Verizon

$52.72

0.36 (0.69%)

BABA

Alibaba

$96.06

-0.11 (-0.11%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Jan

  • 24

    Jan

  • 08

    Feb

PDCO

Patterson Companies

$40.84

0.15 (0.37%)

, XRAY

Dentsply Sirona

$56.01

0.34 (0.61%)

13:10
01/22/17
01/22
13:10
01/22/17
13:10
Periodicals
Patterson Companies could offer 20% return, Barron's says »

The recent decline in…

PDCO

Patterson Companies

$40.84

0.15 (0.37%)

XRAY

Dentsply Sirona

$56.01

0.34 (0.61%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

GME

GameStop

$23.58

0.27 (1.16%)

12:52
01/22/17
01/22
12:52
01/22/17
12:52
Periodicals
GameStop could be a winner, Barron's says »

GameStop has been…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Feb

GOOG

Alphabet

$805.02

2.845 (0.35%)

, GOOGL

Alphabet Class A

$828.17

3.8 (0.46%)

12:41
01/22/17
01/22
12:41
01/22/17
12:41
Periodicals
Alphabet could top $1,000 in a year, Barron's says »

Shares of Alphabet look…

GOOG

Alphabet

$805.02

2.845 (0.35%)

GOOGL

Alphabet Class A

$828.17

3.8 (0.46%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Jan

  • 26

    Jan

SKLN

Skyline Medical

$2.30

-0.12 (-4.96%)

16:50
01/21/17
01/21
16:50
01/21/17
16:50
Conference/Events
Skyline Medical to host special shareholder meeting »

Special Shareholder…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SYMC

Symantec

$26.65

0.09 (0.34%)

, LOCK

LifeLock

$23.93

-0.01 (-0.04%)

16:38
01/21/17
01/21
16:38
01/21/17
16:38
Conference/Events
LifeLock to host special shareholder meeting »

Special Shareholder…

SYMC

Symantec

$26.65

0.09 (0.34%)

LOCK

LifeLock

$23.93

-0.01 (-0.04%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 01

    Feb

  • 08

    Feb

  • 27

    Feb

CMLS

Cumulus Media

16:25
01/21/17
01/21
16:25
01/21/17
16:25
Conference/Events
Cumulus Media to host special shareholder meeting »

Special Shareholder…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AREX

Approach Resources

$3.17

0.03 (0.96%)

16:20
01/21/17
01/21
16:20
01/21/17
16:20
Conference/Events
Approach Resources to host special shareholder meeting »

Special Shareholder…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ERI

Eldorado Resorts

$15.50

-0.05 (-0.32%)

, ISLE

Isle of Capri

$23.75

-0.04 (-0.17%)

15:49
01/21/17
01/21
15:49
01/21/17
15:49
Conference/Events
Isle of Capri to host special shareholder meeting »

Special Shareholder…

ERI

Eldorado Resorts

$15.50

-0.05 (-0.32%)

ISLE

Isle of Capri

$23.75

-0.04 (-0.17%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Jan

ISLE

Isle of Capri

$23.75

-0.04 (-0.17%)

, ERI

Eldorado Resorts

$15.50

-0.05 (-0.32%)

15:45
01/21/17
01/21
15:45
01/21/17
15:45
Conference/Events
Eldorado Resorts to host special shareholder meeting »

Special Shareholder…

ISLE

Isle of Capri

$23.75

-0.04 (-0.17%)

ERI

Eldorado Resorts

$15.50

-0.05 (-0.32%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.